5-14751479-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_054027.6(ANKH):​c.517-240A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 152,184 control chromosomes in the GnomAD database, including 5,372 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5372 hom., cov: 33)

Consequence

ANKH
NM_054027.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.53

Publications

4 publications found
Variant links:
Genes affected
ANKH (HGNC:15492): (ANKH inorganic pyrophosphate transport regulator) This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]
ANKH Gene-Disease associations (from GenCC):
  • chondrocalcinosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • craniometaphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • skeletal dysplasia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • craniometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 5-14751479-T-G is Benign according to our data. Variant chr5-14751479-T-G is described in ClinVar as [Benign]. Clinvar id is 1261660.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKHNM_054027.6 linkc.517-240A>C intron_variant Intron 4 of 11 ENST00000284268.8 NP_473368.1 Q9HCJ1-1
ANKHXM_017009644.3 linkc.433-240A>C intron_variant Intron 4 of 11 XP_016865133.1
ANKHXM_011514067.2 linkc.517-240A>C intron_variant Intron 4 of 8 XP_011512369.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKHENST00000284268.8 linkc.517-240A>C intron_variant Intron 4 of 11 1 NM_054027.6 ENSP00000284268.6 Q9HCJ1-1
ANKHENST00000503939.5 linkn.29-240A>C intron_variant Intron 1 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.254
AC:
38627
AN:
152066
Hom.:
5366
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.358
Gnomad AMI
AF:
0.241
Gnomad AMR
AF:
0.302
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.0797
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.213
Gnomad OTH
AF:
0.255
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.254
AC:
38667
AN:
152184
Hom.:
5372
Cov.:
33
AF XY:
0.251
AC XY:
18695
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.358
AC:
14838
AN:
41486
American (AMR)
AF:
0.302
AC:
4612
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
543
AN:
3470
East Asian (EAS)
AF:
0.105
AC:
545
AN:
5192
South Asian (SAS)
AF:
0.0800
AC:
386
AN:
4828
European-Finnish (FIN)
AF:
0.233
AC:
2465
AN:
10590
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.213
AC:
14471
AN:
68012
Other (OTH)
AF:
0.252
AC:
533
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1472
2944
4416
5888
7360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.256
Hom.:
2310
Bravo
AF:
0.272
Asia WGS
AF:
0.123
AC:
433
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.039
DANN
Benign
0.43
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs697571; hg19: chr5-14751588; COSMIC: COSV107315476; COSMIC: COSV107315476; API